Synaptics Inc (SYNA) 58.42 $SYNA Watch for Synaptics to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Synaptics Inc (SYNA) 58.42 $SYNA

Watch for Synaptics to Potentially Pullback After Gaining 3.26% Yesterday
Comtex SmarTrend(R) - Mon Aug 29, 3:33PM CDT
Synaptics (NASDAQ:SYNA) traded in a range yesterday that spanned from a low of $55.65 to a high of $57.46. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high of $56.55 on volume of 349,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SYNA: 58.42 (+0.35)

Synaptics Sampling Third Generation Natural ID Under-Glass Fingerprint Sensors
GlobeNewswire - Mon Aug 29, 7:00AM CDT
Synaptics Incorporated (NASDAQ:SYNA), the leading developer of human interface solutions, today announced sampling of its new 6x6mm Natural ID FS4500 fingerprint sensor solution. Synaptics' FS4500 solution delivers secure biometric authentication through glass or ceramic buttons, and recessed cover glass up to 300um thick. Durable glass buttons are increasingly being adopted on smartphones, and Synaptics, backed by the industry's most powerful security features, offers a wide array of shapes, sizes and finishes to meet any OEM's requirements.
SYNA: 58.42 (+0.35)

How These Application Software Stocks are Faring? -- Manhattan Associates, Imperva, Synaptics, and Paycom Software
PR Newswire - Wed Aug 17, 6:55AM CDT
Today on Stock-Callers.com we have issued research reports on four Application Software equities, namely, Manhattan Associates Inc. (NASDAQ: MANH), Imperva Inc. (NYSE: IMPV), Synaptics Inc. (NASDAQ: SYNA), and Paycom Software Inc. (NYSE: PAYC). These stocks belong to the Technology sector, which was one of the leading sectors in the market last week. Year-to-date, the Technology Select Sector SPDR Fund (XLK) is up 13%, and is at its highest levels in 16 years. Register now and get full and free access to our downloadable research reports on these stocks at:
SYNA: 58.42 (+0.35), MANH: 61.73 (+0.70), IMPV: 45.94 (+0.47), PAYC: 52.10 (+0.75)

Synaptics to Present at Pacific Crest Global Technology Leadership Forum
GlobeNewswire - Fri Aug 05, 5:30AM CDT
Synaptics Incorporated (NASDAQ:SYNA), the leading developer of human interface solutions, today announced that CEO Rick Bergman will present to the investment community at the Pacific Crest Global Technology Leadership Forum on Monday, August 8, 2016 at 9:30 a.m. Mountain Time in Vail, CO.
SYNA: 58.42 (+0.35)

Synaptics Down 21.7% Since SmarTrend Downtrend Call (SYNA)
Comtex SmarTrend(R) - Thu Aug 04, 1:38PM CDT
SmarTrend identified a Downtrend for Synaptics (NASDAQ:SYNA) on April 29th, 2016 at $70.23. In approximately 3 months, Synaptics has returned 21.73% as of today's recent price of $54.97.
SYNA: 58.42 (+0.35)

After Yesterday's Rally of 7.08% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Aug 01, 3:56PM CDT
Synaptics (NASDAQ:SYNA) traded in a range yesterday that spanned from a low of $51.37 to a high of $56.00. Yesterday, the shares gained 7.1%, which took the trading range above the 3-day high of $54.94 on volume of 753,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SYNA: 58.42 (+0.35)

Synaptics Reports Results for Fourth Quarter and Fiscal 2016
GlobeNewswire - Thu Jul 28, 3:27PM CDT
Synaptics Incorporated (NASDAQ:SYNA), the leading developer of human interface solutions, today reported financial results for its fourth quarter and year ended June 30, 2016.
SYNA: 58.42 (+0.35)

Synaptics (SYNA) Goes on Restructuring Drive, Stock Plunges
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 3:34PM CDT
Shares of Synaptics Inc. (SYNA) fell over 10% on Friday after the company announced a series of restructuring changes.
AMKR: 9.25 (+0.01), SYNA: 58.42 (+0.35), MSFT: 57.67 (+0.08), AAPL: 107.73 (+1.00)

Downtrend Call Working As Synaptics Stock Falls 20.5% (SYNA)
Comtex SmarTrend(R) - Mon Jun 20, 1:34PM CDT
SmarTrend identified a Downtrend for Synaptics (NASDAQ:SYNA) on April 29th, 2016 at $70.23. In approximately 2 months, Synaptics has returned 20.47% as of today's recent price of $55.86.
SYNA: 58.42 (+0.35)

Synaptics Set to Possibly Rebound After Yesterday's Selloff of 10.55%
Comtex SmarTrend(R) - Fri Jun 17, 12:32PM CDT
Synaptics (NASDAQ:SYNA) traded in a range yesterday that spanned from a low of $52.85 to a high of $59.10. Yesterday, the shares fell 10.5%, which took the trading range below the 3-day low of $59.55 on volume of 3.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SYNA: 58.42 (+0.35)

Momentum for FIDO Authentication Leads Evolution Beyond Passwords
Marketwired - Wed Jun 15, 11:13AM CDT
200+ FIDO Certified Products Are Now Available for Simpler, Stronger Authentication
AXP: 65.19 (+0.33), SYNA: 58.42 (+0.35), PYPL: 37.07 (+0.24), DCM: 25.76 (+0.35), BAC: 16.00 (+0.02), NXPI: 88.15 (+0.20), INTC: 36.08 (+0.06), AET: 116.73 (+0.57), GOOG: 771.46 (+2.68), VDSI: 18.86 (+0.49), V: 82.00 (+0.70), QCOM: 63.35 (-0.12), ARMH: 67.77 (+0.33), ING: 12.79 (+0.11), MSFT: 57.67 (+0.08), MA: 97.89 (+0.27), BABA: 99.25 (+1.83)

Application Software Equities Update -- Tableau Software, Splunk, Synaptics, and Shopify
PR Newswire - Wed Jun 08, 7:30AM CDT
On Tuesday, June 07, 2016, the NASDAQ Composite ended the trading session at 4,961.75, down 0.14%; the Dow Jones Industrial Average advanced 0.10% to finish at 17,938.28; and the S&P 500 closed at 2,112.13, up 0.13%. The gains were broad based as eight out of nine sectors ended the session in positive. ActiveWallSt.com has initiated coverage on the following equities: Tableau Software Inc. (NYSE: DATA), Splunk Inc. (NASDAQ: SPLK), Synaptics Inc. (NASDAQ: SYNA), and Shopify Inc. (NYSE: SHOP). Learn more about these stocks by accessing their free trade alerts at:
SHOP: 42.42 (+1.75), SYNA: 58.42 (+0.35), SPLK: 59.39 (+1.20), DATA: 58.46 (+0.43)

Synaptics Set to Possibly Rebound After Yesterday's Selloff of 4.96%
Comtex SmarTrend(R) - Tue Jun 07, 1:24PM CDT
Synaptics (NASDAQ:SYNA) traded in a range yesterday that spanned from a low of $61.82 to a high of $66.99. Yesterday, the shares fell 5.0%, which took the trading range below the 3-day low of $66.09 on volume of 1.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SYNA: 58.42 (+0.35)

Synaptics Natural ID Fingerprint Sensors Featured on ASUS ZenFone 3 Deluxe, Ultra Series
GlobeNewswire - Thu Jun 02, 7:00AM CDT
Synaptics Incorporated (NASDAQ:SYNA), the leading developer of human interface solutions, today announced its Natural ID fingerprint sensors have been selected by ASUS for its flagship ZenFone 3 Deluxe and ZenFone 3 Ultra smartphone series. ASUS chose Synaptics' one-touch fingerprint authentication for its industry-leading high-performance authentication and its unique security features - key traits for swift smartphone access and secure mobile payments.
SYNA: 58.42 (+0.35)

Synaptics' Turnkey USB Fingerprint Solution Adds Simple and Secure Authentication to Notebook PCs
GlobeNewswire - Wed Jun 01, 7:00AM CDT
Synaptics Incorporated (NASDAQ:SYNA), the leading developer of human interface solutions, today announced a new ultra-small form factor USB module that enables Natural ID secure fingerprint authentication on any notebook PC. Synaptics' USB dongle is a turnkey solution for OEMs, ODMs and private labels, enabling them to offer their customers an easy to use and inexpensive fingerprint alternative for PCs lacking integrated biometric sensors.
SYNA: 58.42 (+0.35)

Synaptics Set to Possibly Pullback After Yesterday's Rally of 2.25%
Comtex SmarTrend(R) - Thu May 26, 2:56PM CDT
Synaptics (NASDAQ:SYNA) traded in a range yesterday that spanned from a low of $65.21 to a high of $67.47. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $65.75 on volume of 272,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SYNA: 58.42 (+0.35)

Moving Average Crossover Alert: Synaptics (SYNA)
Zacks Equity Research - Zacks Investment Research - Thu May 26, 8:42AM CDT
Synaptics Inc. (SYNA) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
SYNA: 58.42 (+0.35)

Synaptics Addresses Value-priced Smartphones, Tablets with New ClearPad Touchscreen Controllers
GlobeNewswire - Thu May 26, 7:00AM CDT
Synaptics Incorporated (NASDAQ:SYNA), the leading developer of human interface solutions, today announced two new ClearPad touchscreen controller solutions to address the high volume, value-priced and mid-tier smartphone and tablet markets. Synaptics' feature-rich solutions include the ClearPad S3603 touch controller which targets the smartphone market, and the ClearPad S7611 controller developed for tablets and convertible PCs.
SYNA: 58.42 (+0.35)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 187

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 129

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 287

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Kearney's 2025 Global Cities Report Insights

Updated Category News Views 654

Global Cities Adapt to New Challenges and Emergence Global cities hold steady at the top as new hubs surge forward Top cities reaffirm their dominance in the Global Cities Index, showcasing remarkable resilience amidst global changes and uncertainties. The Global Cities Outlook indicates a noticeable shift as traditional leaders face turbulence, while emerging Gulf and...

Continue Reading
Vacca Family Law Group Enhances Support for Peaceful Divorce

Updated Category News Views 255

Empowering Families Through Non-Adversarial Divorce Solutions Families navigating the challenging process of separation now have renewed access to considerate and non-confrontational divorce options. Vacca Family Law Group has recently welcomed Attorney and Mediator Wendy Reimer, who brings nearly two decades of experience in family law and a strong background in...

Continue Reading
Ingredion Delivers Impressive Q3 Results, Upgrades Outlook

Updated Category News Views 55

Ingredion's Strong Performance in the Third Quarter Ingredion Incorporated (NYSE: INGR) has reported remarkable results for the third quarter of 2024, showcasing a noteworthy surge in both operating income and earnings per share (EPS). The global leader in ingredient solutions for the food and beverage industry achieved a stunning 26% increase in reported operating income...

Continue Reading
Insight into Learning Technologies Group Plc's Disclosure Mechanism

Updated Category News Views 193

Understanding the Public Opening Position Disclosure Process In the complex world of financial securities, understanding the disclosure requirements can feel daunting. However, the process outlined by the Takeover Code, particularly Rule 8.3, provides a structured approach for individuals and entities holding significant interests in relevant securities. This rule is...

Continue Reading
Avidity Biosciences Set to Inspire with Latest Presentations

Updated Category News Views 191

Avidity Biosciences' Key Presentations at the MDA Conference Avidity Biosciences, Inc. (Nasdaq: RNA), a pioneer in RNA therapeutics, is poised to make a significant impact at the upcoming Clinical and Scientific Conference organized by the Muscular Dystrophy Association (MDA). The event will showcase the latest advancements in the field and highlight groundbreaking...

Continue Reading